raloxifene has been researched along with 2,3-bis(4-hydroxyphenyl)-propionitrile in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlson, K; Coletta, CJ; Katzenellenbogen, BS; Katzenellenbogen, JA; Nishiguchi, G; Stauffer, SR; Sun, J; Tedesco, R | 1 |
| Day, BW; Janjic, JM; Sarachine, MJ; Wipf, P | 1 |
2 other study(ies) available for raloxifene and 2,3-bis(4-hydroxyphenyl)-propionitrile
| Article | Year |
|---|---|
Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.
Topics: Binding, Competitive; Estrogen Receptor alpha; Humans; Ligands; Models, Molecular; Phenols; Pyrazoles; Radioligand Assay; Receptors, Estrogen; Structure-Activity Relationship; Transcriptional Activation; Tumor Cells, Cultured | 2000 |
Biphenyl C-cyclopropylalkylamides: New scaffolds for targeting estrogen receptor beta.
Topics: Amides; Antineoplastic Agents; Binding, Competitive; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Estrogen Receptor beta; Humans; Inhibitory Concentration 50; Ligands; Models, Chemical; Protein Binding; Protein Isoforms; Structure-Activity Relationship | 2009 |